NovaBridge Biosciences (NBP) Insider Trading
Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for NovaBridge Biosciences.
Bought (12 mo)
$577,300
Sold (12 mo)
$154,272
Insiders Buying (12 mo)
1
Insiders Selling (12 mo)
3
Form 4 Filings (All Time)
16
Most Recent Purchase
April 28, 2026
Mark Arnold Hagler
President
$577,300
Most Recent Sale
September 21, 2026
Phillip Andrew Dennis
Officer
$5,828
Buys (90d)
0
Sells (90d)
3
Recent Insider Transactions
| Filed | Insider | Role | Type | Value | % Change |
|---|---|---|---|---|---|
| 2026-10-19 | Woo Ian Ying | Director | Exercise | — | — |
| 2026-09-21 | Dennis Phillip Andrew | Officer | Sell | $5,828 | +9.3% |
| 2026-09-11 | Cao Sean Wuxiong | Officer | Sell | $79,904 | -28.8% |
| 2026-09-08 | Cao Sean Wuxiong | Officer | Exercise | — | +967.6% |
| 2026-09-01 | Xu Cong Claire | Officer | Sell | $2,593 | +2.0% |
| 2026-08-25 | Lenz Robert A. | Director | Exercise | — | — |
| 2026-07-10 | Lin Liwei Lorraine | Officer | Award | — | — |
| 2026-07-10 | Hagler Mark Arnold | Officer | Award | — | — |
| 2026-07-08 | Gupta Srishti | CEO | Award | — | — |
| 2026-07-07 | Xu Cong Claire | Officer | Sell | $3,992 | +2.7% |
| 2026-06-30 | Fu Wei | Director | Award | — | — |
| 2026-06-24 | Cao Sean Wuxiong | Officer | Award | — | — |
| 2026-06-22 | Dennis Phillip Andrew | Officer | Sell | $5,606 | +10.1% |
| 2026-06-02 | Xu Cong Claire | Officer | Sell | $13,766 | +2.1% |
| 2026-05-18 | Cao Sean Wuxiong | Officer | Sell | $42,584 | -37.9% |
| 2026-04-28 | Hagler Mark Arnold | Officer | Buy | $577,300 | — |